Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Edwards Lifesciences Corp Director's Dealing 2012

Aug 8, 2012

30042_dirs_2012-08-08_11e019b2-396e-4fd6-a11a-c18a46ca8b79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-08-06

Reporting Person: WANG HUIMIN (CVP, Japan & Intercontinental)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-06 Common Stock M 6250.0000 $21.9550 Acquired 53417.1278 Direct
2012-08-06 Common Stock S 6250.0000 $100.0900 Disposed 47167.1278 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-06 Employee Stock Option (Right to Acquire) $21.9550 M 6250.0000 Disposed 2013-05-10 Common Stock (6250.0000) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2011.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.